Last edition
News about "finished dosage formulation "
Laurus Labs Posts Strong Q1 FY26 Results With 31 Percent Revenue Growth
Laurus Labs has reported strong financial results for the first quarter of FY26, with consolidated revenues reaching INR 1,570 crore—a 31 percent year-on-year increase.
Finished Dosage Formulation | 26/07/2025 | By Dineshwori | 564
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members